bioAffinity Technologies (BIAF) Other financing activities (2024 - 2026)

bioAffinity Technologies (BIAF) has reported Other financing activities for 3 consecutive years, with -$4.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other financing activities fell 182.33% year-over-year to -$4.5 million; the TTM figure through Dec 2025 stood at $4.8 million (up 404.93% YoY), while the FY2025 annual figure was $4.8 million, up 251.09% from the prior year.
• Other financing activities eased to -$4.5 million in Q4 2025 per BIAF's latest filing, from $7.7 million in the prior quarter.
• Across five years, Other financing activities topped out at $7.7 million in Q3 2025 and bottomed at -$6.0 million in Q4 2022.
• Historically, Other financing activities has averaged -$339649.1 across 3 years, with a median of $73.5 in 2024.
• On a YoY basis, Other financing activities climbed as much as 1463.66% in 2025 and fell as far as 182.33% in 2025.
• bioAffinity Technologies' Other financing activities stood at -$6.0 million in 2022, then jumped by 73.48% to -$1.6 million in 2024, then tumbled by 182.33% to -$4.5 million in 2025.
• Business Quant data shows BIAF's Other financing activities at -$4.5 million in Q4 2025, $7.7 million in Q3 2025, and $387407.0 in Q2 2025.